TP8, A Novel Chondroinductive Peptide, Significantly Promoted Neo-Cartilage Repair without Activating Bone Formation
Mingjing Zhu1,2, Siqing Jiang1, Xingyang Li1
1Department of Temporomandibular Joint, School and Hospital of Stomatology, Guangdong Engineering Research Center of Oral Restoration and Reconstruction & Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Guangzhou Medical University, Guangzhou, 510180, China.
Advanced Healthcare Materials
|December 18, 2024
Summary
A novel peptide, TP8, derived from transforming growth factor β3 (TGF-β3), effectively promotes cartilage regeneration by activating mesenchymal stem cells (MSCs). This peptide shows significant potential for cartilage tissue engineering applications.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Orthopedic Surgery
Background:
- Large cartilage defects pose significant challenges in orthopedic and maxillofacial surgery.
- Chondroinductive agents that activate endogenous mesenchymal stem cells (MSCs) are crucial for cartilage regeneration.
Purpose of the Study:
- To develop a novel chondroinductive peptide, TP8, derived from transforming growth factor β3 (TGF-β3).
- To evaluate TP8's efficacy in inducing cartilage formation and regeneration.
Main Methods:
- Analysis of TGF-β3's critical binding domain crystallographic data.
- Development and testing of TP8 in vitro using bone marrow MSCs (BMSCs).
- In vivo assessment of TP8 in rabbit cartilage defect models.
Main Results:
- TP8 induced ectopic cartilage formation without significant bone formation.
- TP8 enhanced glycosaminoglycans (GAGs) and proteoglycans (PGs) secretion and chondrogenic marker expression in BMSCs.
- TP8 significantly upregulated SRY-box transcription factor 9 (Sox9) expression and Smad1/5 phosphorylation.
- TP8 promoted neo-cartilage formation with a thicker deep zone in rabbit cartilage defects.
Conclusions:
- TP8 is a novel chondroinductive peptide with potential for cartilage regeneration.
- TP8's mechanism involves activating MSCs and upregulating Sox9 expression via Lrp1.
- TP8 demonstrates promising therapeutic potential in cartilage tissue engineering.
Related Concept Videos
01:27Growth of Cartilage and Bone Tissue
3.0K
Chondrocytes form a temporary cartilaginous model by dividing and secreting a thick gel-like extracellular matrix. Once the chondrocytes undergo programmed cell death, osteoblasts enter the site of the cartilaginous model. The process of replacing the temporary cartilaginous model with bone in an ordered manner is called endochondral ossification. In endochondral ossification, not all of the cartilage is replaced by bone tissue. Some cartilage that performs a protective and supportive function...
3.0K
01:27Fractures: Bone Repair
2.9K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
2.9K